Metraipolis › archive › dc_ef268dd808d1
Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms — Europe PMC PMID:41256221
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41256221
- DOI
- 10.1002/smsc.202500270
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T02:54:45.070Z
- SHA-256 of the archived text
33bb36eeee782a4970bf651a8663e2f63a66bf8d82576c40b65d759320ef6823- Stable URL of this page
https://metraipolis.com/documento/dc_ef268dd808d1
How to cite
Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms — Europe PMC PMID:41256221 — Europe PMC (en), https://europepmc.org/article/MED/41256221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef268dd808d1 (Metraipolis archive dc_ef268dd808d1, sha256 33bb36eeee782a4970bf651a8663e2f63a66bf8d82576c40b65d759320ef6823)
BibTeX
@misc{dcef268dd808d1,
title = {Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms — Europe PMC PMID:41256221},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41256221},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef268dd808d1; sha256 33bb36eeee782a4970bf651a8663e2f63a66bf8d82576c40b65d759320ef6823},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41256221. Agents can read the archived copy with the MCP tool read_document.